Pathophysiological substantiation of the effectiveness of quercetine use in coronavirus disease (COVID-19) therapy
In the absence of effective and safety therapy for COVID-19 patients, today the search for new methods of treatment is the most actual topic in medicine and pharmacy. High mortality (7.1 %) due to the development of acute respiratory distress-syndrome, which is caused by cytokine storm, dictate the...
Saved in:
Main Authors: | I. A. Zupanets (Author), S. K. Shebeko (Author), N. P. Bezugla (Author), I. A. Otrishko (Author) |
---|---|
Format: | Book |
Published: |
Zaporozhye State Medical University,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
by: Igor A. Zupanets, et al.
Published: (2019) -
Study of the effect of phytocomposition based on the drug "Arthritan" on the ultrastructure of cartilage in rats with systemic steroid arthritis
by: Yu. M. Naboka, et al.
Published: (2020) -
N-acetylglucosamine increases the efficacy of quercetin in the treatment of experimental acute kidney injury
by: Sergii K. Shebeko, et al.
Published: (2020) -
Quercetin as a potential nutraceutic against coronavirus disease 2019 (COVID-19)
by: Júlio César Moreira Brito, et al.
Published: (2021) -
Pathophysiological mechanisms of coronavirus disease (COVID-19) progression and fatal complications in patients with diabetes
by: T. O. Briukhanova, et al.
Published: (2020)